Since it was discovered that the hazards of body hormone therapy outweighed the benefits, researchers have been looking for a safe, healthy way to ease the indications of Women
Participants are currently staying recruited for a follow-up medical trial of a treatment known as MF101 manufactured by Bionovo, Incorporation. In its initial clinical trial, MF101 presented women in the study with preliminary evidence of relief from many of these symptoms because hot flashes and night time sweats, with no risks linked to hormone remedy.
The treatment getting tested medically targets merely one of the two known estrogen receptors-the estrogen receptor beta. Laboratory data has shown that MF101 will not cause the proliferation of breast or perhaps uterine tumor cells just how hormone remedy can, making the medication a more secure alternative to currently available hormone remedies.
In 2002, the Might Health Gumption (WHI) Estrogen Plus Progestin Trial, with over sixteen, 000 women of all ages participants, was stopped early on when it was found the fact that standard dose of combo hormone remedy increased the chance of breast cancer, heart stroke, heart episodes, blood clots and dementia.
“Given the void that exists for a safe and effective treatment for menopausal symptoms, our aim should be to discover and develop novel drugs such as MF101 that will abate most of the symptoms that contain historically recently been treated with hormones, very well said Doctor Mary Tagliaferri. Tagliaferri is co-author of “The Fresh Menopause E book: The Experts Help you produce Informed Decisions on HRT, Natural Hormone Therapy, Organic Therapies, Classic Chinese Medicine And More” (Avery, 2006) and Chief Medical Officer of Bionovo, which is developing the drug.
The clinical trials will take place under the directorship of renowned researcher Dr . Deborah Grady at 4 leading academic medical centers.
Bionovo can expect this Stage 2 trial to be completed by the second one fourth of 2018.
“If the brand new drug attests to be effective, we will be providing health care practitioners having a treatment they will comfortably recommend to women of all ages experiencing menopause, ” explained Dr . Tagliaferri.